Showing all 3 results
Daclatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dihydrochloride Salt Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the active virological agent.
Active Ingredient Strength Primary Clinical Function Daclatasvir Dihydrochloride USP/Ph.Eur. 60 mg The Standard Eradication Macrodose: The definitive, globally standardized daily therapeutic payload utilized for the vast majority of patients to achieve a Sustained Virologic Response (SVR12 – Clinical Cure). Daclatasvir Dihydrochloride USP/Ph.Eur. 30 mg The CYP3A4 Titration Unit: The strict, mandatory dose-reduction unit utilized for patients who are co-infected with HIV and taking strong CYP3A inhibitors (like Ritonavir or Atazanavir). Excipients Anhydrous Lactose / Microcrystalline Cellulose / Croscarmellose Sodium / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film (Opadry Green) Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced dissolution-enhancing matrices to ensure the Dihydrochloride salt separates perfectly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Heavy-Gauge HDPE Bottles of 28 (Optimized exactly for a 4-week supply in strict 12-week or 24-week curative regimens).
Sofosbuvir & Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Ledipasvir INN/Ph.Eur. 90 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir & Velpatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict 12-week clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Velpatasvir INN/Ph.Eur. 100 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution)
